Author

Carlos Henrique Alves Jesus

Indiana University BloomingtonORCID 0000-0002-3308-0022Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Andrea G. HohmanniD· 3 shared Jonah L. WirtiD· 2 shared Ai-Ling Li· 1 shared Alexandros MakriyannisiD· 1 shared Emily Fender SizemoreiD· 1 shared Gopireddy Raghavender ReddyiD· 1 shared Heather B. BradshawiD· 1 shared Jenna A. HimelsteiniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Andrea G. HohmannORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Acetaminophen alters endogenous lipid signaling and attenuates pathological pain through a mechanism requiring diacylglycerol lipase, monoacylglycerol lipase and cannabinoid CB1 receptors in mice

Carlos Henrique Alves Jesus, Jonah L. Wirt, Taylor J. Woodward, Luana Assis Ferreira, Wenwen Du, John Hainline, Mirjam C. W. Huizenga, Lara Rems, Alexandros Makriyannis, Jenna A. Himelstein, Noah M. Brauer, Mario van der Stelt, Heather B. Bradshaw, Andrea G. Hohmann

This study shows acetaminophen reduces pain by altering lipid signaling via cannabinoid receptors and enzymes in mice.

Neuropharmacology · Sep 7, 2026Peer-reviewedNeuroscience

Cannabidiol attenuates chemotherapy-induced peripheral neuropathic pain through a mechanism that requires the enzyme N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD)

Carlos Henrique Alves Jesus, Ai-Ling Li, Serge H. Luquet, Ken Mackie, Andrea G. Hohmann

This study shows CBD reduces chemotherapy-induced neuropathic pain through NAPE-PLD and PPAR receptor pathways, but not CB1/CB2.

bioRxiv · Jun 12, 2026 · PreprintNeuroscience

CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathy

Carlos Henrique Alves Jesus, Gopireddy Raghavender Reddy, Emily Fender Sizemore, Jonah L. Wirt, Swastik Sen, Richard C. Yu, Toshihiko Takeuchi, Lauren J. Schwimmer, Andrea G. Hohmann

This study evaluates CB2-specific antibody agonists for treating chemotherapy-induced peripheral neuropathy, showing pain relief without tolerance or off-target effects.

bioRxiv · Nov 26, 2025 · PreprintNeuroscience